1 February 2022 - The Febuary 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.

There are two major new listings this month - casirivimab with imdevimab (Ronapreve) and baricitinib (Olumiant) for patients with COVID-19 infection. These listings were announced in January.

Note the price of Ronapreve is not published; so much for improved transparency.

The update to the Schedule makes no mention of the listing of baricitinib as it will be used in hospitals (i.e. listed in Hospital Schedule).

Read New Zealand Pharmaceutical Schedule update